The B.C. Ministry of Health is conducting a survey of patients, caregivers, and advocacy groups to achieve input regarding osteoporosis therapies in British Columbia and B.C. PharmaCare coverage.
We know that coverage for osteoporosis medications in British Columbia is among the worst in Canada. All treatments for osteoporosis covered by PharmaCare require a “special authority” form to be filled by a physician and the criteria for special authority are very restrictive.
For example, to achieve coverage for certain therapeutic agents, a patient requires a fragility fracture and either an allergy to bisphosphonate or an obstruction to swallowing a pill.
Intolerance, other contraindication to oral bisphosphonate, and even failure on oral bisphosphonate therapy are not included in the criteria for special authority.
The Ministry of Health is soliciting patient input.
Please consider making your voice heard as this may benefit not only your circumstance but that of many other osteoporosis patients in British Columbia.
Patients, caregivers and patient groups can share their experience and opinions with the B.C. Ministry of Health by completing a Your Voice survey.
PharmaCare regularly reviews drugs to decide if they should provide coverage for people enrolled in PharmaCare plans.
PharmaCare considers the drug’s safety, how well it works and how expensive it is, among other factors. It usually takes about 15-20 minutes to fill out a survey.
The patient and caregiver survey will only be available on the B.C. government “Your Voice” website from October 20 to November 17, 2021.